Skip to content

Azenta AZTA EV / sales

EV / sales at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
5.1×-0.9×
Danaher logo
DanaherDHR
-0.8×
Labcorp Holdings logo
Labcorp HoldingsLH
+0.1×
Illumina logo
IlluminaILMN
4.5×+1.4×
CryoPort, Inc. logo
CryoPort, Inc.CYRX
0.0×
Twist Bioscience Corporation logo
Twist Bioscience CorporationTWST
7.1×+0.7×

Other financials

Income statement

See full
Revenue$144.8M+1.0%
Gross profit$62.0M-1.2%
Operating income-$165.8M-811%
Net income-$160.8M-237%
EPS (diluted)-$3.49-236%

Balance sheet

See full
Cash & equivalents$125.2M
Total debt$55.7M
Total equity$1.6B-8.3%
Total assets$1.9B

Cash flow

See full
Operating cash flow$13.5M-6.2%
CapEx$7.4M-0.1%
Free cash flow$6.1M-12.7%

Valuation

See full
Market cap$1.1B-19.0%
Enterprise value$1.03B
P/S1.8×-0.3×

Profitability

See full
Gross margin40%-1.0pp
Operating margin-31.6%-59.7pp
Net margin-29.1%-80.7pp
FCF margin8.6%

Returns & leverage

See full
Return on equity-10.7%-22.4pp
Debt / equity
Current ratio2.8×

Where this comes from

Calculated from Azenta’s reported figures.

Based on the most recent quarter.

The official record: Azenta’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Azenta's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Azenta's EV / sales?
Azenta (AZTA) reported EV / sales of 1.5× in Q1 2026.
What is the long-term trend for Azenta's EV / sales?
Over 4 years (2020 to 2025), Azenta's EV / sales has grown at a -29.6% compound annual growth rate (CAGR), from 8.4× to 2.1×.
What does EV / sales mean?
Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.